The effects of fucodian on senescence are controlled by the p16 INK4a-pRb and p14Arf-p53 pathways in hepatocellular carcinoma and hepatic cell lines

International Journal of Oncology

Volumn 45, Issue 1, 2014, Pages 47-56

  Min, Eun Young ^a   Kim, In Hye ^a   Lee, Jungim ^a   Kim, Eun Young ^a   Choi, Youn Hee ^a   Nam, Taek Jeong ^a  

^a Pukyong National University   (South Korea)

Author keywords

Anti senescence; Anti tumor; Fucoidan

Indexed keywords

ALPHA 2 MACROGLOBULIN; BETA GALACTOSIDASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FUCOIDIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; ANTINEOPLASTIC AGENT; POLYSACCHARIDE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; SIGNAL TRANSDUCTION; UPREGULATION; CELL LINE; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; HEPG2 CELL LINE; LIVER TUMOR; METABOLISM; PATHOLOGY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; POLYSACCHARIDES; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION;

EID: 84902590550     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2426     Document Type: Article

References (50)

1. Li Y, Nichols MA, Shay JW and Xiong Y: Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 54: 6078-6082, 1994.
2. Dürig J, Vruhn T, Zurborn KH, Gutensohn K, Bruhn HD and Bėress L: Anticoagulant fucoidan fractions from Fucus vesiculosus induce platelet activation in vitro. Thromb Res 85: 479-491, 1997.
3. Maruyama H, Tamauchi H, Hasimoto M and Nakano T: Antitumor activity and immune response of Mekabu fucoidan extracted from Sporophyll of Undaria pinnatifida. In vivo 17: 245-249, 2003.
4. Wang J, Zhang Q, Zang Z and Li Z: Antioxidant activity of sulfated polysaccharide fractions extracted from Laminaria japonica. Int J Biol Macromol 42: 127-132, 2008.
5. Hu T, Liu D, Chen Y, Wu J and Wang S: Antioxidant activity of sulfated polysaccharide fractions extracted from Undaria pinnitafida in vitro. Int J Biol Macromol 46: 193-198, 2010.
6. Lee H, Kim JS and Kim E: Fucoidan form seaweed Fucus vesiculosus inhibits migration and invasion of human lung cancer cells via PI3K-Akt-mTOR pathways. PLoS One 7: e50624, 2012.
7. Xue M, Ge Y, Zhang J, et al: Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo. PLoS One 7: e43483, 2012.
8. Kim NY, Sun JM, Kim YJ, et al: Cisplatin-based combination chemotherapy for advanced hepatocellular carcinoma: a single centre experience before the sorafenib era. Cancer Res Treat 42: 203-209, 2010.
9. Rayess H, Wang MB and Srivatsan ES: Cellular senescence and tumor suppressor gene p16. Int J Cancer 130: 1715-1725, 2012.
10. Krishnamurthy J, Torrice C, Ramsey MR, et al: Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114: 1299-1307, 2004.
11. Stein GH, Drullinger LF, Soulard A and Dulić V: Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 19: 2109-2117, 1999.
12. Li B, Lu F, Wei X and Zhao R: Fucoidan: structure and bioactivity. Molecules 13: 1671-1695, 2008.
13. Hara E, Smith R, Parry D, Tahara H, Stone S and Peters G: Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16: 859-867, 2008.
14. Arf. Cell 91: 555-558, 1997.
15. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92: 713-723, 1998.
16. Arf tumor suppressor. Mol Cell Biol 20: 273-285, 2000.
17. Sharpless NE: INK4a/ARF: A multifunctional tumor suppressor locus. Mutat Res 576: 22-38, 2005.
18. Han J and Sun P: 2007. The pathways to tumor suppression via route p38. Trends Biochem Sci 32: 364-371, 2007.
19. Bulavin DV and Fornace AJ Jr: p38 MAPK kinase's emerging role as a tumor suppressor. Adv Cancer Res 92: 95-118, 2004.
20. INK4a. Cell 88: 593-602, 1997.
21. Ma H, Li R, Zhang Z and Tong T: mRNA level of alpha-2-macroglobulin as an aging biomarker of human fibroblasts in culture. Exp Gerontol 39: 415-421, 2004.
22. Serrano M: The INK4a/ARF locus in murine tumorigenesis. Carcinogenesis 21: 865-869, 2000.
23. INK4a contributes to the outcome of cancer therapy. Cell 109: 335-346, 2002.
24. Schumacher M, Kelkel M, Dicato M and Diederich M: Gold from the sea: marine compounds as inhibitors of the hallmarks of cancer. Biotechnol Adv 29: 531-547, 2011.
25. Ishii H, Iwatsuki M, Ieta K, et al: Cancer stem cells and chemoradiation resistance. Cancer Sci 99: 1871-1877, 2008.
26. Alekseyenko TV, Zhanayeva SY, Venediktova AA, et al: Antitumor and antimetastatic activity of fucoidan, a sulfated polysaccharide isolated from the Okhotsk Sea Fucus evanescens brown alga. Bull Exp Biol Med 143: 730-732, 2007.
27. Meek DW: 2009. Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer 9: 714-723, 2009.
28. INK4a is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 5: 379-389, 2006.
29. Melzer D: Genetic polymorphisms and human aging: association studies deliver. Rejuvenation Res 11: 523-526, 2008.
30. Fedorov SN, Shubina LK, Bode AM, Stonik VA and Dong Z: Dactylone inhibits epidermal growth factor-induced transformation and phenotype expression of human cancer cells and induces G1-S arrest and apoptosis. Cancer Res 67: 5914-5920, 2007.
31. Park C, Kim GY, Kim GD, et al: Suppression of U937 human monocytic leukemia cell growth by dideoxypetrosynol A, a polyacetylene from the sponge Petrosia sp., via induction of Cdk inhibitor p16 and down-regulation of pRB phosphorylation. Oncol Rep 16: 171-176, 2006.
32. Müller M, Strand S, Hug H, et al: Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 99: 403-413, 1997.
33. Vogelstein B, Lane D and Levine AJ: Surfing the p53 network. Nature 408: 307-310, 2000.
34. Fujii H, Honoki K, Tsujiuchi T, et al: Reduced expression of INK4a/ARF genes in stem-like sphere cells from rat sarcomas. Biochem Biophysic Res Commun 362: 773-778, 2007.
35. Deng J, Qian Y, Geng L, et al: Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (HepG2). Liver Int 28: 1458-1464, 2008.
36. Wang YX, Xu XY, Su WL, et al: Activation and clinical significance of p38 MAPK signaling pathway in patients with severe trauma. J Surg Res 161: 119-125, 2009.
37. Hyun JH, Kim SC, Kang JI, et al: Apoptosis inducing activity of fucoidan in HCT-15 colon carcinoma cells. Biol Pharm Bull 32: 1760-1764, 2009.
38. Iyoda K, Sasaki Y, Horimoto M, et al: Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma. Cancer 97: 3017-3026, 2003.
39. Wagner EF and Nebreda AR: Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549, 2009.
40. Schyschka L, Rudy A, Jeremias I, Barth N, Pettit GR and Vollmar AM: Spongistatin 1: a new chemosensitizing marine compound that degrades XIAP. Leukemia 22: 1737-1745, 2008.
41. Igney FH and Krammer PH: Death and anti-death: tumor resistance to apoptosis. Nat Rev Cancer 2: 277-288, 2002.
42. Verzola D, Gandolfo MT, Gaetani G, et al: Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. Am J Physiol Renal Physiol 295: F1563-F1573, 2008.
43. INK4a tumor suppressor. Proc Natl Acad Sci USA 106: 16562-16567, 2009.
44. INK4a and the control of cellular proliferative life span. Carcinogenesis 20: 921-926, 1999.
45. INK4a expression. J Biol Chem 276: 48325-48331, 2001.
46. INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat Cell Biol 2: 148-155, 2000.
47. Jung YS, Qian Y and Chen X: Examination of the expanding pathway for the regulation of p21 expression and activity. Cell Signal 22: 1003-1012, 2010.
48. Collado M, Blasco MA and Serrano M: Cellular senescence in cancer and aging. Cell 130: 223-233, 2007.
49. Tahara H, Sato E, Noda A and Ide T: Increase in the expression level of p21sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts. Oncogene 10: 835-840, 1995.
50. Kondo T, Sakaguchi M, and Namba M: Two-dimensional gel electrophoresis studies on the cellular aging: accumulation of alpha-2-macroglobulin in human fibroblasts with aging. Exp Gerontol 36: 487-495, 2001.